Hilltop National Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.91K Hold
50
﹤0.01% 693
2026
Q1
$6.39K Hold
50
﹤0.01% 697
2025
Q4
$6.1K Hold
50
﹤0.01% 690
2025
Q3
$5.01K Hold
50
﹤0.01% 708
2025
Q2
$4.15K Buy
+50
New +$3.99K ﹤0.01% 711
2024
Q4
$4.5K Hold
50
﹤0.01% 695
2024
Q3
$4.94K Hold
50
﹤0.01% 730
2024
Q2
$4.64K Hold
50
﹤0.01% 723
2024
Q1
$4.75K Buy
+50
New +$4.64K ﹤0.01% 694

Other funds holding XBI

Hilltop National Bank's XBI Position: Q2 2026 in Review

Hilltop National Bank held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 50 shares worth $7.91K. The position accounts for ﹤0.01% of the portfolio, ranked #693.

Hilltop National Bank first reported a position in XBI in Q1 2024 and has held it in 9 quarters since. 260 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Hilltop National Bank held 50 shares of State Street SPDR S&P Biotech ETF worth $7.91K as of Q2 2026.
  • Hilltop National Bank left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Hilltop National Bank's portfolio in Q2 2026, its #693 holding.
  • Hilltop National Bank first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 9 quarters since.
  • 260 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.